Skip to content

Comparison of the therapeutic effects of Euphorbia Helioscopia latex with cryotherapy on common and plantar warts

Comparison of the therapeutic effects of Euphorbia Helioscopia latex with cryotherapy on common and plantar warts

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180807040734N1
Enrollment
100
Registered
2018-10-14
Start date
2018-08-06
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

common and plantar warts. Viral warts

Interventions

Intervention 1: Intervention group 1: one side plantar and common warts?intervention In this group is the use of Euphorbia helioscopia latex? fresh and topically proportional to the size of the warts
Intervention group 2: common and plantar warts in the otherside, intervention in this group will use cryotherapy with the prescribed therapeutic standards. It will be done at the first session and 2,

Sponsors

Ardabil University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 40 Years

Inclusion criteria

Inclusion criteria: age 5-40 y. having bilateral common or plantar warts negative PMH Collaboration can be provided to the patient by the end of the project The patient has the consent to cooperate

Exclusion criteria

Exclusion criteria: pregnancy any systemic diseases metabolic disorders and any positive PMH uncontrollable side effects Failure to continue cooperation by the patient

Design outcomes

Primary

MeasureTime frame
The amount of warts resized in response to treatment with euphorbia helioscopia latex and cryotherapy. Timepoint: In the first visit and after 2,4 and 6 w.and 6 months after the last session of treatment. Method of measurement: With colis the largest diameter of the warts is measured and with anatomical position is recorded.

Secondary

MeasureTime frame
Pain score during the treatment. Timepoint: At the first session of treatment. Method of measurement: A score 0 to 10 will be given by the patient separately for each treatment intervention in the first session.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Majid Rostami

Ardabil University of Medical Sciences

ava.bohlooli@arums.ac.ir+98 45 3345 2206

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026